TSLA vs. CRSP

Last updated Jun 6, 2026

TSLA (Tesla, Inc.) and CRSP (CRISPR Therapeutics AG) are both stocks. TSLA operates in Auto Manufacturers (Consumer Cyclical), while CRSP operates in Biotechnology (Healthcare). Over the past 5 years, TSLA returned 14.38%/yr vs -14.47%/yr for CRSP. At a 0.32 correlation, their price movements are largely independent.

Performance

TSLA vs. CRSP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tesla, Inc. (TSLA) and CRISPR Therapeutics AG (CRSP). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, TSLA achieves a -13.06% return, which is significantly lower than CRSP's -1.14% return.

TSLA

• 1D: -6.56%
• 1M: -1.94%
• YTD: -13.06%
• 6M: -14.07%
• 1Y: 37.34%
• 3Y*: 20.89%
• 5Y*: 14.38%
• 10Y*: 38.11%

CRSP

• 1D: -8.97%
• 1M: -5.88%
• YTD: -1.14%
• 6M: -8.86%
• 1Y: 34.40%
• 3Y*: -7.06%
• 5Y*: -14.47%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

TSLA vs. CRSP - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TSLA Tesla, Inc.	-13.06%	11.36%	62.52%	101.72%	-65.03%	49.76%	743.44%	25.70%	6.89%	45.70%
CRSP CRISPR Therapeutics AG	-1.14%	33.23%	-37.12%	54.00%	-46.36%	-50.51%	151.39%	113.18%	21.68%	15.89%

Correlation

The correlation between TSLA and CRSP is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.33
Correlation (5Y) Calculated over the trailing 5-year period	0.39
Correlation (All Time) Calculated using the full available price history since Oct 20, 2016	0.32

Fundamentals

Market Cap TSLA : $1.38T CRSP : $4.98B
EPS TSLA : $1.10 CRSP : -$6.24
PS Ratio TSLA : 14.10 CRSP : 1.15K
PB Ratio TSLA : 16.45 CRSP : 2.74
Total Revenue (TTM) TSLA : $97.88B CRSP : $4.10M
Gross Profit (TTM) TSLA : $18.66B CRSP : -$171.17M
EBITDA (TTM) TSLA : $10.48B CRSP : -$509.21M

Return for Risk

TSLA vs. CRSP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TSLA

TSLA Risk / Return Rank: 64
TSLA Sharpe Ratio Rank: 68
TSLA Sortino Ratio Rank: 63
TSLA Omega Ratio Rank: 60
TSLA Calmar Ratio Rank: 65
TSLA Martin Ratio Rank: 66

CRSP

CRSP Risk / Return Rank: 58
CRSP Sharpe Ratio Rank: 60
CRSP Sortino Ratio Rank: 59
CRSP Omega Ratio Rank: 56
CRSP Calmar Ratio Rank: 60
CRSP Martin Ratio Rank: 56

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TSLA vs. CRSP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tesla, Inc. (TSLA) and CRISPR Therapeutics AG (CRSP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TSLA	CRSP	Difference
Sharpe ratio: Return per unit of total volatility	0.84	0.55	+0.30
Sortino ratio: Return per unit of downside risk	1.39	1.22	+0.17
Omega ratio: Gain probability vs. loss probability	1.16	1.14	+0.02
Calmar ratio: Return relative to maximum drawdown	1.25	0.82	+0.44
Martin ratio: Return relative to average drawdown	2.93	1.38	+1.55
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TSLA vs. CRSP - Sharpe Ratio Comparison

The current TSLA Sharpe Ratio is 0.84, which is higher than the CRSP Sharpe Ratio of 0.55. The chart below compares the historical Sharpe Ratios of TSLA and CRSP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	TSLA	CRSP	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.84	0.55	+0.30
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.25	-0.24	+0.48
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.65	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.72	0.23	+0.49

Drawdowns

TSLA vs. CRSP - Drawdown Comparison

The maximum TSLA drawdown since its inception was -73.63%, smaller than the maximum CRSP drawdown of -85.11%. Use the drawdown chart below to compare losses from any high point for TSLA and CRSP.

Drawdown Indicators

	TSLA	CRSP	Difference
Max Drawdown Largest peak-to-trough decline	-73.63%	-85.11%	+11.48%
Max Drawdown (1Y) Largest decline over 1 year	-29.93%	-42.25%	+12.32%
Max Drawdown (3Y) Largest decline over 3 years	-53.77%	-64.91%	+11.14%
Max Drawdown (5Y) Largest decline over 5 years	-73.63%	-80.68%	+7.05%
Max Drawdown (10Y) Largest decline over 10 years	-73.63%	—	—
Current Drawdown Current decline from peak	-20.18%	-75.32%	+55.14%
Average Drawdown Average peak-to-trough decline	-22.73%	-49.19%	+26.46%
Ulcer Index Depth and duration of drawdowns from previous peaks	12.80%	25.06%	-12.26%

Volatility

TSLA vs. CRSP - Volatility Comparison

The current volatility for Tesla, Inc. (TSLA) is 13.89%, while CRISPR Therapeutics AG (CRSP) has a volatility of 19.12%. This indicates that TSLA experiences smaller price fluctuations and is considered to be less risky than CRSP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TSLA	CRSP	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.89%	19.12%	-5.23%
Volatility (6M) Calculated over the trailing 6-month period	27.83%	43.66%	-15.83%
Volatility (1Y) Calculated over the trailing 1-year period	46.71%	62.97%	-16.26%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	58.87%	60.69%	-1.82%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.13%	64.38%	-5.25%

Dividends

TSLA vs. CRSP - Dividend Comparison

Neither TSLA nor CRSP has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both TSLA and CRSP in my portfolio?

TSLA and CRSP have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, TSLA or CRSP?

CRSP has higher volatility (19.12%) compared to TSLA (13.89%). In terms of maximum drawdown, TSLA dropped -73.63% vs CRSP's -85.11%.

Which has better risk-adjusted returns?

TSLA currently has the higher Sharpe Ratio (0.84 vs 0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.